Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The closing price of Replimune Group Inc (NASDAQ: REPL) was $13.94 for the day, down -0.85% from the previous closing price of $14.06. In other words, the price has decreased by -$0.85 from its previous closing price. On the day, 0.6 million shares were traded. REPL stock price reached its highest trading level at $14.14 during the session, while it also had its lowest trading level at $13.49.
Ratios:
Our analysis of REPL’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 10.11 and its Current Ratio is at 10.11. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.19.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, ROTH MKM on August 28, 2024, initiated with a Buy rating and assigned the stock a target price of $17.
On November 19, 2021, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $52.Piper Sandler initiated its Overweight rating on November 19, 2021, with a $52 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 16 ’24 when Patel Sushil sold 10,000 shares for $12.42 per share. The transaction valued at 124,200 led to the insider holds 202,014 shares of the business.
Sushil Patel bought 15,000 shares of REPL for $188,550 on Dec 16 ’24. On Nov 18 ’24, another insider, Xynos Konstantinos, who serves as the Chief Medical Officer of the company, sold 7,246 shares for $10.78 each. As a result, the insider received 78,112 and left with 109,885 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, REPL now has a Market Capitalization of 1072763840 and an Enterprise Value of 597804160.
Stock Price History:
The Beta on a monthly basis for REPL is 1.29, which has changed by 0.7534591 over the last 52 weeks, in comparison to a change of 0.19995654 over the same period for the S&P500. Over the past 52 weeks, REPL has reached a high of $17.00, while it has fallen to a 52-week low of $4.92. The 50-Day Moving Average of the stock is 9.90%, while the 200-Day Moving Average is calculated to be 34.81%.
Shares Statistics:
REPL traded an average of 904.94K shares per day over the past three months and 634420 shares per day over the past ten days. A total of 68.39M shares are outstanding, with a floating share count of 61.36M. Insiders hold about 18.55% of the company’s shares, while institutions hold 81.83% stake in the company. Shares short for REPL as of 1736899200 were 7261267 with a Short Ratio of 8.02, compared to 1734048000 on 5927772. Therefore, it implies a Short% of Shares Outstanding of 7261267 and a Short% of Float of 13.020000000000001.
